A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Otsuka Pharmaceuticals could shell out over $400 million in total for the Asia-Pacific rights to 4D-150, which combines a ...
Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...
King Faisal Specialist Hospital & Research Centre (KFSHRC) has begun in-house manufacturing and clinical use of CAR-T cell ...
Alps Group Inc (the "Company" or "Alps Group"), the parent company of Alps Life Sciences Inc. ("Alps Holdco"), a fully integrated ...
Alps Group Inc (the "Company” or "Alps Group”), the parent company of Alps Life Sciences Inc. ("Alps Holdco”), a fully integrated biotechnology research and healthcare platform specializing in ...
Vancouver, Canada, Oct. 31, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel ...
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...
Milestone advances MEAI-based therapy targeting a global Alcohol Use Disorder treatment market projected to surpass $20 billion by 2032 Vancouver, Canada, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Clearmind ...
Patients gain hope through regenerative medicine doctors earn empowerment and recognition and India gains economic momentum through reduced chronic burden and enhanced GDP growth.Dr. Polisetty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback